VIDEO: Possible cancer mortality risk for patients with RA-ILD
Click Here to Manage Email Alerts
In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, offered take home messages from a study focused on rheumatoid arthritis-associated interstitial lung disease, or RA-ILD, presented at ACR 2020.
The study explored total risk for mortality as well as cause-specific mortality.
“Patients with RA-ILD were actually at an increased risk for cancer mortality and that’s a novel direction as far as trying to monitor patients not just for regression of their underlying RA-ILD but as a progression for cancer and cancer death,” Sparks, who is also an assistant professor of medicine at Harvard Medical School, said.
Collapse
Healio Interview
Sparks JA, et al. Abstract #0489. Presented at: ACR Convergence 2020; November 5-9, 2020 (virtual meeting).
Click Here to Manage Email Alerts